Violation Tracker Individual Record
Opioid manufacturer Insys Therapeutics agreed to a global resolution to settle federal criminal and civil investigations regarding its sale of the powerful opioid Subsys. As part of the criminal resolution, Insys entered into a deferred prosecution agreement, pled guility to five counts of mail fraud, and paid a $2 million fine and $28 million in forfeiture. As part of the civil resolution, Insys agreed to pay $195 million to settle allegations that it violated the False Claims Act. Both the criminal and civil investigations stemmed from Insys's payment of kickbacks and other unlawful marketing practices in connection with the marketing of Subsys.